Latest news with #ZAVA
Yahoo
2 days ago
- Business
- Yahoo
HIMS Stock Falls Despite Latest Deal to Expand International Footprint
Hims & Hers Health, Inc. HIMS announced its agreement to acquire ZAVA, a digital health platform in Europe. The deal, which marks a significant step toward its global expansion, will likely expand HIMS' footprint in the U.K. and will officially launch the company into Germany, France and Ireland, with more markets anticipated soon. The acquisition is expected to close in the second half of 2025, and the deal is expected to be accretive by 2026. Hims & Hers is also planning to introduce a new, personalized dimension of digital health in Europe. Through this, the company aims to provide individuals with access to care tailored to their specific needs and goals across dermatology, weight loss, sexual health and mental health. To ensure a localized experience, this expansion is also expected to include access to British, German and French healthcare providers in local languages. Hims & Hers expects to share more about the offerings and their rollout in the coming months. The latest acquisition and subsequent expansion in the European markets are expected to significantly solidify HIMS' international footprint. Following the announcement, shares of the company lost nearly 3.6% till yesterday's closing. Historically, the company has gained synergies from its various strategic buyouts. Although the latest deal is likely to be beneficial for HIMS' top-line growth going forward, the stock declined overall. Hims & Hers currently has a market capitalization of $12.25 billion. It has an earnings yield of 1.3%, favorable than the industry's negative yield. In the last reported quarter, HIMS delivered an earnings surprise of 66.7%. Hims & Hers aims to establish its own branded presence, leveraging the ZAVA platform in each of the European markets in the coming quarters and strengthening its digital health offerings on a global scale. It is worth mentioning that ZAVA, which currently serves more than 1.3 million active customers, has an in-house medical team that delivered nearly 2.3 million consultations in 2024 across the U.K., Germany, France and Ireland. Hims & Hers' management expects to leverage ZAVA's established European presence to transform access to care for people across Europe battling widespread, often silent chronic conditions like obesity and depression. Per a report by Grand View Research, the global digital health market was estimated at $288.55 billion in 2024 and is anticipated to witness a CAGR of 22.2% between 2025 and 2030. Factors like the rising incidence of chronic conditions fueling the demand for remote monitoring and management solutions, and technological advancements are likely to drive the market. Given the market potential, the latest buyout is expected to be a significant milestone for Hims & Hers and boost its business globally. In February, Hims & Hers acquired a U.S.-based peptide facility based in California. The buyout will likely enable the company to strengthen the long-term durability of its domestic supply chain to meet the growing demand from Americans for personalized healthcare and treatment options. The same month, Hims & Hers acquired an at-home lab testing facility, Sigmund NJ LLC, which is marketed as Trybe Labs. The buyout will likely enable HIMS to support at-home blood draws and more comprehensive whole-body testing. The acquisition is also expected to broaden the company's ability to offer a wide range of personalized treatments, supplements and medications and accelerate the expansion into new clinical categories, including low testosterone, perimenopausal and menopausal support. Shares of the company have surged 154.1% in the past year compared with the industry's 33.8% rise and the S&P 500's gain of 11.4%. Image Source: Zacks Investment Research Currently, HIMS carries a Zacks Rank #2 (Buy). A few other top-ranked stocks in the broader medical space are HealthEquity, Inc. HQY, Cencora, Inc. COR and Integer Holdings Corporation ITGR. HealthEquity, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 20.3%. HQY's earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 12.4%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. HealthEquity's shares have gained 34.9% against the industry's 21.7% decline in the past year. Cencora, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 12.8%. COR's earnings surpassed estimates in each of the trailing four quarters, the average surprise being 6%. Cencora has rallied 25.3% against the industry's 21.7% decline in the past year. Integer Holdings, sporting a Zacks Rank of 1 at present, has an estimated long-term growth rate of 18.4%. ITGR's earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 2.8%. Integer Holdings' shares have lost 0.7% compared with the industry's 13.2% plunge in the past year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cencora, Inc. (COR) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report Integer Holdings Corporation (ITGR) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Business
- Yahoo
Hims & Hers Expands in Europe With Acquisition of ZAVA
Hims & Hers expanding in Europe with the purchase of London-based digital health platform ZAVA. The acquisition gives the health and wellness site an increased reach in the U.K., and launches the firm in Germany, France, and Ireland. The price of the all-cash deal was not & Hers Health (HIMS) shares rose Tuesday after the health and wellness site announced it was expanding its reach into Europe by buying London-based digital health platform ZAVA. The price of the all-cash deal was not disclosed. Hims & Hers explained that the purchase will increase its presence in the U.K., and give the firm an entry into Germany, France, and Ireland, "with more markets anticipated soon." Founder and CEO Andrew Dudum said by leveraging ZAVA's "established European presence, cutting-edge technology, and deep customer understanding, we're poised to fundamentally transform access to care for millions across Europe." The company added that it would soon introduce "a new, personalized dimension of digital health in Europe, providing individuals with access to care tailored to their specific needs and goals across dermatology, weight loss, sexual health and mental health." Hims & Hers noted that the acquisition would be paid for from the company's balance sheet, and is expected to close in the second half of this year. It expects the addition of ZAVA to be accretive by next year. Shares of Hims & Hers advanced about 3% in recent trading and have soared about 130% this year. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 days ago
- Business
- Business Wire
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced a significant step in its global expansion through its agreement to acquire ZAVA, a leading digital health platform in Europe. This strategic move will expand Hims & Hers' footprint in the United Kingdom and will officially launch the company into Germany, France, and Ireland, with more markets anticipated soon. This acquisition is expected to accelerate Hims & Hers' vision to deliver the same seamless, personalized care experience it has successfully built in the U.S. to millions more people globally. Hims & Hers will establish its own branded presence, leveraging the robust ZAVA platform, in each of these European markets in the coming quarters. By combining ZAVA's trusted European operations, medical rigor, and seamless digital experience with Hims & Hers' proven, trusted brand, the company is poised to become a leader in digital health globally, delivering access to personalized care that meets people where they are. This strategic acquisition will significantly strengthen Hims & Hers' international footprint. Serving more than 1.3 million active customers, ZAVA's in-house medical team delivered nearly 2.3 million consultations in 2024 across the UK, Germany, France, and Ireland. Hims & Hers will soon introduce a new, personalized dimension of digital health in Europe, providing individuals with access to care tailored to their specific needs and goals across dermatology, weight loss, sexual health and mental health. To ensure a world-class and localized experience, this expansion will include access to British, German, and French healthcare providers in local languages. While Hims & Hers will share more about the offerings and their rollout in the coming months, they expect the deal to be accretive by 2026. 'The demand for simpler, more personalized healthcare is universal,' said Andrew Dudum, founder and CEO of Hims & Hers. 'By leveraging ZAVA's established European presence, cutting-edge technology, and deep customer understanding, we're poised to fundamentally transform access to care for millions across Europe. Whether in rural towns, vibrant cities, or remote communities across Europe, people battling widespread, often silent chronic conditions like obesity, depression, and more will have access to the personalized, high-quality care they deserve.' 'Wherever you live, the need is the same: healthcare that's personal, trustworthy and fast. By joining forces with Hims & Hers, we can put that standard within reach of millions more people across Europe,' said David Meinertz, co-founder and CEO of ZAVA. 'Together we'll pair ZAVA's trusted clinical services, established footprint, and deep understanding of the European healthcare landscape with the Hims & Hers experience to make affordable access to high-quality, personalized care the rule, not the exception. I'm thrilled to be working with Andrew and his team. It's still day one for digital healthcare, and I can't wait to see what we'll achieve for patients in the years ahead.' The acquisition consideration will be comprised of 100% cash, to be funded from the company's balance sheet at closing. The acquisition is expected to close in the second half of 2025, and Hims & Hers expects to continue expanding globally as demand for personalized healthcare continues to grow. For more information, please see About Hims & Hers Health, Inc Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That's why we're building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit and About ZAVA ZAVA is a leading digital health platform in Europe, on a mission to make high-quality, dependable healthcare accessible and affordable. Serving more than 1.3 million active customers, ZAVA's in-house medical team delivered nearly 2.3 million consultations in 2024 across the UK, Germany, France and Ireland - putting compassionate, clinically-robust healthcare in people's hands 24/7. Rated 'outstanding' for leadership by the UK Care Quality Commission, ZAVA combines medical rigour with a friction-free digital experience. ZAVA's comprehensive service portfolio spans weight management, women's and men's health, sexual health, general medicine and skin & hair care - helping people tackle both everyday and sensitive conditions quickly, discreetly and safely. Cautionary Note Regarding Forward-Looking Statements Except for historical information, certain statements in this press release, including statements regarding the timing and effects of entering into the acquisition described above, our future performance, anticipated customer demand, the ability to scale our business, the solutions accessible on our platform, and the underlying assumptions with respect to the foregoing, are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, and are subject to risks, uncertainties and assumptions about Hims & Hers and its business. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties related to market conditions, our legal and regulatory environment, macroeconomic and geopolitical factors, and those factors described in the 'Risk Factors' section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Securities and Exchange Commission (the 'Commission'). Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These risks and others described in the 'Risk Factors' section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Commission may not be exhaustive.
Associated Press
3 days ago
- Business
- Associated Press
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
SAN FRANCISCO--(BUSINESS WIRE)--Jun 3, 2025-- Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced a significant step in its global expansion through its agreement to acquire ZAVA, a leading digital health platform in Europe. This strategic move will expand Hims & Hers' footprint in the United Kingdom and will officially launch the company into Germany, France, and Ireland, with more markets anticipated soon. This acquisition is expected to accelerate Hims & Hers' vision to deliver the same seamless, personalized care experience it has successfully built in the U.S. to millions more people globally. Hims & Hers will establish its own branded presence, leveraging the robust ZAVA platform, in each of these European markets in the coming quarters. This press release features multimedia. View the full release here: This strategic move will expand Hims & Hers' footprint in the United Kingdom and will officially launch the company into Germany, France, and Ireland, with more markets anticipated soon. By combining ZAVA's trusted European operations, medical rigor, and seamless digital experience with Hims & Hers' proven, trusted brand, the company is poised to become a leader in digital health globally, delivering access to personalized care that meets people where they are. This strategic acquisition will significantly strengthen Hims & Hers' international footprint. Serving more than 1.3 million active customers, ZAVA's in-house medical team delivered nearly 2.3 million consultations in 2024 across the UK, Germany, France, and Ireland. Hims & Hers will soon introduce a new, personalized dimension of digital health in Europe, providing individuals with access to care tailored to their specific needs and goals across dermatology, weight loss, sexual health and mental health. To ensure a world-class and localized experience, this expansion will include access to British, German, and French healthcare providers in local languages. While Hims & Hers will share more about the offerings and their rollout in the coming months, they expect the deal to be accretive by 2026. 'The demand for simpler, more personalized healthcare is universal,' said Andrew Dudum, founder and CEO of Hims & Hers. 'By leveraging ZAVA's established European presence, cutting-edge technology, and deep customer understanding, we're poised to fundamentally transform access to care for millions across Europe. Whether in rural towns, vibrant cities, or remote communities across Europe, people battling widespread, often silent chronic conditions like obesity, depression, and more will have access to the personalized, high-quality care they deserve.' 'Wherever you live, the need is the same: healthcare that's personal, trustworthy and fast. By joining forces with Hims & Hers, we can put that standard within reach of millions more people across Europe,' said David Meinertz, co-founder and CEO of ZAVA. 'Together we'll pair ZAVA's trusted clinical services, established footprint, and deep understanding of the European healthcare landscape with the Hims & Hers experience to make affordable access to high-quality, personalized care the rule, not the exception. I'm thrilled to be working with Andrew and his team. It's still day one for digital healthcare, and I can't wait to see what we'll achieve for patients in the years ahead.' The acquisition consideration will be comprised of 100% cash, to be funded from the company's balance sheet at closing. The acquisition is expected to close in the second half of 2025, and Hims & Hers expects to continue expanding globally as demand for personalized healthcare continues to grow. For more information, please see About Hims & Hers Health, Inc Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That's why we're building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit and About ZAVA ZAVA is a leading digital health platform in Europe, on a mission to make high-quality, dependable healthcare accessible and affordable. Serving more than 1.3 million active customers, ZAVA's in-house medical team delivered nearly 2.3 million consultations in 2024 across the UK, Germany, France and Ireland - putting compassionate, clinically-robust healthcare in people's hands 24/7. Rated 'outstanding' for leadership by the UK Care Quality Commission, ZAVA combines medical rigour with a friction-free digital experience. ZAVA's comprehensive service portfolio spans weight management, women's and men's health, sexual health, general medicine and skin & hair care - helping people tackle both everyday and sensitive conditions quickly, discreetly and safely. Cautionary Note Regarding Forward-Looking Statements Except for historical information, certain statements in this press release, including statements regarding the timing and effects of entering into the acquisition described above, our future performance, anticipated customer demand, the ability to scale our business, the solutions accessible on our platform, and the underlying assumptions with respect to the foregoing, are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, and are subject to risks, uncertainties and assumptions about Hims & Hers and its business. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties related to market conditions, our legal and regulatory environment, macroeconomic and geopolitical factors, and those factors described in the 'Risk Factors' section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Securities and Exchange Commission (the 'Commission'). Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These risks and others described in the 'Risk Factors' section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Commission may not be exhaustive. View source version on CONTACT: Press Contact Susan Cadrecha [email protected] KEYWORD: CALIFORNIA IRELAND UNITED STATES FRANCE UNITED KINGDOM NORTH AMERICA EUROPE GERMANY INDUSTRY KEYWORD: HEALTH TELEMEDICINE/VIRTUAL MEDICINE FITNESS & NUTRITION GENERAL HEALTH VITAMINS/SUPPLEMENTS PHARMACEUTICAL SOURCE: Hims & Hers Copyright Business Wire 2025. PUB: 06/03/2025 07:15 AM/DISC: 06/03/2025 07:15 AM
Daily Record
24-05-2025
- Health
- Daily Record
'Number one' exercise that burns the most calories unveiled - and it may surprise you
Exercise is crucial for managing weight, maintaining heart health, and enhancing overall well-being The 'number one' exercise that burns the most calories has been revealed. Burning calories through activities such as exercise is crucial for managing weight, maintaining heart health, and enhancing overall well-being. It aids in weight loss by establishing a calorie deficit, lowering the risk of chronic illnesses, and boosting both physical and mental health. Despite regularly exercising being one of the best activities for good health, less than half of the people in the UK exercise (48%), according to PureGym data. However, with the peak holiday season approaching and summer on the way, gyms are poised to get more crowded. Summer is the most popular season to work out, studies show, with 45% of people keeping active, much higher than in winter, where 76% of Brits admit they steer clear of exercise. Whether you are new to the gym or not, knowing the most effective workouts can be confusing. With that in mind, the weight loss specialists at ZAVA have revealed the exercises that burn the most calories, reports Surrey Live. Exercises that burn the most calories. Exercises that burn the most calories Rank Exercise Calories (Kcal) burned per 10 min (Male) Calories (Kcal) burned per 10 min (Female) 1 Running curved treadmill, 7.0 to 7.9 mph 184 155 =2 Skipping 168 142 =2 Rowing - stationary 168 142 =2 Shuttle running 168 142 =2 High-intensity interval exercises (HIIT) 168 142 3 Bicycling - stationary 165 139 =4 Ski ergometer 161 135 =4 Slide board exercise 161 135 5 Kettlebell swings 150 126 6 Therapeutic exercise ball, Fitball exercise 145 122 =7 Stair climber 142 120 =7 Boxing, simulated boxing round, exercise 142 120 =8 Elliptical trainer 138 116 =8 Jumping rope - Digi-Jump Machine 138 116 =8 Impulse Training System 138 116 9 Pound 130 109 10 122 103 The experts at ZAVA have revealed that the exercise which burns the most calories per 10 minutes is running on a curved treadmill at 7-7.9mph. This exercise burns 184 calories for men and 155 for women. The speed is a 'sweet spot' as dropping down to 4-4.9mph reduces calories burnt by 77 on average. While it may seem surprising that curved treadmills offer better benefits than regular flat treadmills, they are seen as superior. This is largely due to the fact that they are self-powered, mimicking a more natural running experience and increasing calorie burn, muscle engagement of glutes, hamstrings and calves with a lower impact on joints. In joint second place with 168 calories burnt in 10 minutes for men and 142 for women are skipping, shuttle running, high intensity interval training (HIIT) and rowing on a machine. Skipping rope exercises are a fantastic way to burn calories with minimal equipment, and one that you can do at home with just a rope - 168 calories burnt in 10 minutes for men and 142 for women. Skipping is a fantastic exercise that can get your heart pumping, build muscle, strength and explosiveness, increase endurance, and even improve balance and coordination. It is an exercise that can be easily tailored to your skill and energy levels. It is suitable for all ages and has even been shown to boost bone density. A small study in 2015 involving women aged between 25-50 found that those who skipped twice a day saw significant improvement in hip bone density after eight weeks. Rowing is another great option, burning 168 calories in 10 minutes for men and 142 for women. This full-body exercise helps improve heart health, endurance, muscle strength and can even enhance posture. High-intensity interval training (HIIT) also burns the same amount of calories. This form of exercise involves short bursts of intense activity and can be done alone or in classes with individual movements such as burpees, mountain climbers, and squat jumps. Research suggests that your metabolic rate is higher after HIIT workouts. The workout can also increase your VO2 max - the maximum amount of oxygen your body can absorb and use during exercise, a great way to indicate an individual's aerobic capacity. Shuttle runs are another effective exercise, also burning 168 calories in 10 minutes for men and 142 for women. Shuttle runs are popular with individuals and athletes looking to improve acceleration, deceleration, speed and aerobic health. The 20m shuttle run, also known as the beep test, is commonly used as an assessment for physically demanding jobs as an indicator of VO2 max. Popular exercises such as yoga and Pilates are among the least efficient in burning calories, with men burning 35 and 43 calories respectively in 10 minutes, and women burning 30 and 36. Despite these popular exercises not burning a high number of calories, they are crucial tools used by many to enhance core strength, flexibility and have significant benefits for mental health. Some exercises are more suitable for some than others. Consult your GP if you have any queries about your fitness.
